CODX Co-Diagnostics: Prakiraan wutah bathi kanggo taun ngarep

Logo grafis Co-Diagnostics Inc (CODX)

Shrinking demand for PCR tests has forced Co-Diagnostics, Inc. (CODX) to develop portable rapid diagnostics for small clinics. Patents for Co-Dx Design home systems serve as a hedge against dumping in an oversaturated sector. Shifts in target earnings per share estimates confirm this trend, where 72.90 captures the magnitude of this parameter. Revenues are based on the supply of DNA equipment and molecular tests for global medical centers.

CoDx (CODX): Prakiraan wutah bathi resik saben saham ing taun ngarep saka 04.07.2022 nganti 14.11.2026

Rincian analitis perusahaan codiagnostics.com (CODX)

Analisis wiwitan perusahaan:Co-Diagnostics Corp, CODX
Produk dadi codiagnostics.com

When selecting stocks, asset reliability is determined by the projected return on equity. This indicator measures the expected percentage growth in earnings per share for the following year, currently reaching a value of 72.90. For Co-Diagnostics, Inc. (CODX), this calculation confirms the commercialization of new PCR systems and the stability of the R&D pipeline; therefore, the valuation of future earnings per share dynamics serves as a signal of the business's fundamental resilience.

Pesaing utama

Prakiraan wutah bathi resik saben saham kanggo taun ngarep Agilent Tech|Quest Corp (DGX) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep ILMN|Prakiraan wutah bathi saben saham kanggo taun ngarep exactsciences.com EXAS|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Revvity RVTY|Bio-Rad Laboratories, Inc. (BIO) - Prakiraan wutah bathi resik saben saham ing taun ngarep|NNNN: Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Nordion (SHC)|QDEL: Prakiraan wutah bathi kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep OPK|CDNA (CareDx, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Maravai LifeSciences Holdings (MRVI) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep FLGT|Prakiraan wutah bathi kanggo taun ngarep Standard BioTools Corp (LAB)|Prakiraan wutah bathi kanggo taun ngarep CTKB (Cytek Biosciences, Inc.)|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep orasure.com|XGN - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|MDXH (MDxHealth S.A.) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Lucid Diagnostics Inc (LUCD) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Prenetics (PRE)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Insight Molecular Diagnostics, Inc.|Trinity Biotech Corp (TRIB) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep PRPH (ProPhase Labs)|Proyeksi tambahing bathi saben saham ing taun ngarep AIMD|Prakiraan wutah bathi kanggo taun ngarep HSCS (Heart Test Laboratories Inc.)|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Biomerica Inc (BMRA)|Cardio Diagnostics Holdings, Inc. - Prakiraan wutah bathi kanggo taun ngarep|onconetix.gcs-web.com (ONCO) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Virax Biolabs (VRAX) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|BJDX - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep AWH|AXDX: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep CNTG|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep enzo.com|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Fresh2 Group FRES|GENE: Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|23andMe Inc. - Prakiraan wutah bathi kanggo taun ngarep|Psychemedics Inc (PMD) - Prakiraan wutah bathi saben saham kanggo taun ngarep